Cardinal Health (CAH)
(Real Time Quote from BATS)
$102.87 USD
-0.50 (-0.48%)
Updated Apr 24, 2024 11:14 AM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Income Statements
Fiscal Year end for Cardinal Health, Inc falls in the month of June .
All items in Millions except EPS data.
6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 | |
---|---|---|---|---|---|
Sales | 205,012 | 181,364 | 162,467 | 152,922 | 145,534 |
Cost Of Goods | 198,123 | 174,819 | 155,689 | 146,054 | 138,700 |
Gross Profit | 6,889 | 6,545 | 6,778 | 6,868 | 6,834 |
Selling & Adminstrative & Depr. & Amort Expenses | 6,162 | 7,141 | 6,306 | 10,966 | 4,774 |
Income After Depreciation & Amortization | 727 | -596 | 472 | -4,098 | 2,060 |
Non-Operating Income | 4 | -24 | 31 | 564 | -15 |
Interest Expense | 93 | 149 | 180 | 238 | 294 |
Pretax Income | 638 | -769 | 323 | -3,772 | 1,751 |
Income Taxes | 376 | 163 | -289 | -79 | 386 |
Minority Interest | 1 | 1 | 1 | 3 | 2 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 262 | -932 | 612 | -3,693 | 1,365 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 261 | -933 | 611 | -3,696 | 1,363 |
Depreciation Footnote | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1,419 | 96 | 1,255 | -3,185 | 3,060 |
Depreciation & Amortization (Cash Flow) | 692 | 692 | 783 | 913 | 1,000 |
Income After Depreciation & Amortization | 727 | -596 | 472 | -4,098 | 2,060 |
Earnings Per Share Data | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 |
---|---|---|---|---|---|
Average Shares | 262.00 | 279.00 | 294.00 | 293.00 | 301.00 |
Diluted EPS Before Non-Recurring Items | 5.79 | 5.06 | 5.57 | 5.45 | 5.28 |
Diluted Net EPS (GAAP) | 1.00 | -3.35 | 2.08 | -12.61 | 4.53 |
Fiscal Year end for Cardinal Health, Inc falls in the month of June .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 57,445.00 | 54,763.00 | 53,453.00 | 50,487.00 |
Cost Of Goods | NA | 55,599.00 | 52,995.00 | 51,626.00 | 48,702.00 |
Gross Profit | NA | 1,846.00 | 1,768.00 | 1,827.00 | 1,785.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 1,364.00 | 1,782.00 | 1,690.00 | 1,213.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 482.00 | -14.00 | 137.00 | 572.00 |
Non-Operating Income | NA | 16.00 | 2.00 | -1.00 | 0.00 |
Interest Expense | NA | 8.00 | 14.00 | 15.00 | 28.00 |
Pretax Income | NA | 490.00 | -26.00 | 121.00 | 544.00 |
Income Taxes | NA | 136.00 | -32.00 | 187.00 | 197.00 |
Minority Interest | NA | 1.00 | 1.00 | -2.00 | 2.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 354.00 | 6.00 | -66.00 | 347.00 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 353.00 | 5.00 | -64.00 | 345.00 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 246.00 | 250.00 | 254.00 | 258.00 |
Diluted EPS Before Non-Recurring Items | NA | 1.82 | 1.73 | 1.55 | 1.74 |
Diluted Net EPS (GAAP) | NA | 1.43 | 0.02 | -0.24 | 1.34 |